Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Mallinckrodt
Covington
US Department of Justice
Julphar
QuintilesIMS
Baxter
AstraZeneca
Cerilliant
Fuji

Generated: February 19, 2018

DrugPatentWatch Database Preview

Hikma Company Profile

« Back to Dashboard

What is the competitive landscape for HIKMA, and when can generic versions of HIKMA drugs launch?

HIKMA has one hundred and fifty-six approved drugs.

There are five US patents protecting HIKMA drugs on HIKMA drugs in the past three years. There are two tentative approvals on HIKMA drugs.

Summary for Hikma
US Patents:5
Tradenames:117
Ingredients:110
NDAs:156

Drugs and US Patents for Hikma

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hikma Farmaceutica ONDANSETRON HYDROCHLORIDE ondansetron hydrochloride INJECTABLE;INJECTION 076781-001 Dec 26, 2006 AP RX No No ➤ Sign Up ➤ Sign Up
Hikma Intl Pharms LITHIUM CARBONATE lithium carbonate TABLET;ORAL 078715-001 Dec 28, 2010 DISCN No No ➤ Sign Up ➤ Sign Up
Hikma Pharms PIROXICAM piroxicam CAPSULE;ORAL 209256-001 Aug 11, 2017 AB RX No No ➤ Sign Up ➤ Sign Up
Hikma Farmaceutica CEFAZOLIN SODIUM cefazolin sodium INJECTABLE;INJECTION 065143-001 Oct 18, 2004 AP RX No No ➤ Sign Up ➤ Sign Up
Hikma Pharms TOPIRAMATE topiramate TABLET;ORAL 091185-004 Nov 25, 2013 DISCN No No ➤ Sign Up ➤ Sign Up
Hikma Farmaceutica ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE ondansetron hydrochloride INJECTABLE;INJECTION 076780-001 Dec 26, 2006 AP RX No No ➤ Sign Up ➤ Sign Up
Hikma CIPROFLOXACIN HYDROCHLORIDE ciprofloxacin hydrochloride TABLET;ORAL 076558-004 Jun 9, 2004 AB RX No No ➤ Sign Up ➤ Sign Up
Hikma GABAPENTIN gabapentin CAPSULE;ORAL 078150-003 Sep 25, 2007 DISCN No No ➤ Sign Up ➤ Sign Up
Hikma Pharms DANTROLENE SODIUM dantrolene sodium INJECTABLE;INJECTION 204762-001 Jun 19, 2017 AP RX No No ➤ Sign Up ➤ Sign Up
Hikma Farmaceutica VALPROATE SODIUM valproate sodium INJECTABLE;INJECTION 078523-001 Feb 17, 2010 AP RX No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for HIKMA drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Capsules 0.6 mg ➤ Subscribe 6/10/2016
➤ Subscribe Injection 1 mg/mL, 50 mL vials ➤ Subscribe 12/16/2011
➤ Subscribe Injection 100 mg/mL, 2.5 mL vials ➤ Subscribe 9/24/2007
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Colorcon
Chubb
Accenture
Deloitte
McKesson
US Army
Julphar
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot